Get the latest Science News and Discoveries
Next-generation treatments hitch a ride into cancer cells - EurekAlert
<p>Researchers from Osaka University found that a new activator called L687 induces cancer cells to accept delivery of antisense oligonucleotide (ASO) drugs. These drugs can treat cancer by blocking the transfer of messages from genes that encourage cancer growth. Previous methods to deliver ASOs into cells had only limited success. This research will help accelerate the development and delivery of novel ASO cancer therapies.</p>
None
Or read this on Eureka Alert